← Leaderboards
Paloma Hoban Giangrande
University Of Iowa
$1,727,326
Attributed
$1,932,451
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $534K · FY2009–13$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,932,451 · 2
By mechanism
R01$1,522,201 · 1
R21$410,250 · 1
Top collaborators
- Aloysius John Klingelhutz2 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Aliasger K Salem$2,971,479
- John H Lee$4,646,355
- Elaine M. Smith$5,017,147
- John F Engelhardt$56,184,900
- Aloysius John Klingelhutz$4,574,727
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelBinding (Molecular Function)GrowthMalignant NeoplasmsSmall Interfering RnaCellsComplexGenesLaboratoriesLeadReagentSafetySpecificityPublic Health RelevanceAptamerCancer CellEpithelial CellsErbb2 GeneChimera OrganismIn VivoBreast Cancer TreatmentBreast Cancer CellAnimal ModelBreast
Grant awards (7)
Aptamer-siRNA Chimeras Targeting HER2-Positive Breast Cancers$295,875
R01 · FY2013 · CA · contact PI
Aptamer-siRNA Chimeras Targeting HER2-Positive Breast Cancers$301,913
R01 · FY2012 · CA · contact PI
Aptamer-siRNA Chimeras Targeting HER2-Positive Breast Cancers$301,913
R01 · FY2011 · CA · contact PI
Aptamer-siRNA Chimeras Targeting HER2-Positive Breast Cancers$311,250
R01 · FY2010 · CA · contact PI
Novel Chimeric RNA Aptamer Technology to Treat Head and Neck Cancer$222,750
R21 · FY2010 · DE
Aptamer-siRNA Chimeras Targeting HER2-Positive Breast Cancers$311,250
R01 · FY2009 · CA · contact PI
Novel Chimeric RNA Aptamer Technology to Treat Head and Neck Cancer$187,500
R21 · FY2009 · DE